OHSU study advances understanding of TDP-43 protein in ALS

Dennis Hazelett, Ph.D., a postdoctoral fellow in the Morton Lab, is lead author on the paper.

A new study by researchers at the OHSU School of Dentistry advances our understanding of how a protein, TDP-43, impacts gene expression in neurodegenerative diseases like ALS. The researchers altered levels of TDP-43 in fruit flies to directly compare too much versus too little of the protein. Using massively parallel sequencing, they found that loss of TDP-43 results in widespread gene activation and altered splicing. Over expression resulted in decreased gene expression–a finding contrary to previous studies that indicated both loss-of-function and over expression may cause ALS.

For more information, check out the OHSU News release, or read the full paper, published this month in G3: Genes, Genomes, Genetics.

This study was supported by grants from the National Institutes of Health (NS071186); the ALS Association; and the Muscular Dystrophy Association.

Bookmark and Share

Comments are closed.

About the Author

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Read more

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.

Categories

Archives